Aehr Test Systems' Shares Offer Buying Opportunity After Titan HP Selloff, Oppenheimer Says

MT Newswires Live10-14 23:36

Aehr Test Systems (AEHR) recent share-price decline following Teradyne's (TER) Titan HP announcement appears overdone and creates a "buying opportunity," Oppenheimer said in a report Wednesday, after meeting with management at the CEO Summit.

The firm said concerns about competition are "overdone" because Teradyne's Titan HP remains primarily a "system-level test" platform, while Aehr's FOX system performs accelerated-life burn-in at the wafer level. That distinction limits the competitive overlap and reinforces FOX's differentiation, particularly for high-power artificial intelligence devices where "localized hotspots" and thermal runaway can complicate reliability testing.

Oppenheimer also sees longer-term opportunity from "broader hyperscaler adoption" and higher-value FOX configurations, while a second major AI processor remains a "key catalyst." However, it said meaningful high-volume manufacturing adoption could be "gradual" because the system still needs pilot-production validation in Taiwan, according to the report.

Oppenheimer maintained its estimates, outperform rating and $120 price target, on Aehr Test Systems.

Price: 73.51, Change: -4.00, Percent Change: -5.17

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment